Anzeige
Mehr »
Login
Samstag, 28.05.2022 Börsentäglich über 12.000 News von 666 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PPX6 ISIN: US72941H4002 Ticker-Symbol: XMPA 
Frankfurt
27.05.22
08:01 Uhr
0,511 Euro
+0,025
+5,10 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
PLUS THERAPEUTICS INC Chart 1 Jahr
5-Tage-Chart
PLUS THERAPEUTICS INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,5310,54213:00
0,5130,56027.05.

Aktuelle News zur PLUS THERAPEUTICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
20.05.PLUS THERAPEUTICS, INC. - 8-K, Current Report-
18.05.Plus Therapeutics Inc.: Plus Therapeutics to Present Virtually at the 2022 HC Wainwright Global Investment Conference4
PLUS THERAPEUTICS Aktie jetzt für 0€ handeln
26.04.Plus Therapeutics Inc.: Plus Therapeutics to Present at the 2022 Q2 Investor Summit6
22.04.Quest Diagnostics Boosts Outlook, Danaher's EPS & Revenue Rise, PSTV Braces For Busy Year505WASHINGTON (dpa-AFX) - The following healthcare companies reported quarterly earnings on Thursday.1. Quest Diagnostics Inc. (DGX), which reported a 4% decline in revenue for the first quarter...
► Artikel lesen
21.04.Plus Therapeutics Inc. Loss at -$4.12 Mln in Q1313WASHINGTON (dpa-AFX) - Plus Therapeutics Inc. (PSTV) revealed Loss for first quarter of -$4.12 millionThe company's earnings totaled -$4.12 million, or -$0.19 per share. This compares with -$2.72...
► Artikel lesen
21.04.Plus Therapeutics GAAP EPS of -$0.19 misses by $0.015
21.04.PLUS THERAPEUTICS, INC. - 10-Q, Quaterly Report3
19.04.Plus Therapeutics Inc.: Plus Therapeutics Announces Oral Presentation at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2022 Annual Meeting-
14.04.Plus Therapeutics Inc.: Plus Therapeutics to Announce First Quarter 2022 Financial Results and Host Conference Call on April 21, 20224
08.04.Plus Therapeutics Inc.: Plus Therapeutics Announces Poster Presentation at the American Association for Cancer Research (AACR) Annual Meeting5
05.04.Plus Therapeutics, Medidata partner for glioblastoma therapy trial1
05.04.PLUS THERAPEUTICS, INC. - 8-K, Current Report1
05.04.Plus Therapeutics Inc.: Plus Therapeutics and Medidata Announce Expanded Clinical Trial Partnership3
03.03.Plus Therapeutics Inc.: Plus Therapeutics Announces Upcoming Participation at the 2022 SNMMI Therapeutics Conference6
24.02.Plus Therapeutics GAAP EPS of -$1.11 misses by $0.018
24.02.PLUS THERAPEUTICS, INC. - 8-K, Current Report2
22.02.Plus Therapeutics, Medidata team up for synthetic control arm solution in trial3
22.02.Plus Therapeutics Inc.: Plus Therapeutics Partners with Medidata to Apply Innovative Synthetic Control Arm? Solution to Accelerate Brain Cancer Clinical ...1
18.02.Plus Therapeutics Inc.: Plus Therapeutics to Announce Fourth Quarter and Full Year 2021 Financial Results and Host Conference Call on February 24, 20224
07.02.Plus Therapeutics Inc.: Plus Therapeutics to Present at BIO CEO & Investor Conference5
Seite:  Weiter >>
31 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1